| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/2011 | US20110124845 Process for protein extraction |
| 05/26/2011 | US20110124844 Selective and Specific Preparation of Discrete Peg Compounds |
| 05/26/2011 | US20110124841 Polypeptides Modified by Protein Trans-Splicing Technology |
| 05/26/2011 | US20110124840 Synthesis of Homopolymers and Block Copolymers |
| 05/26/2011 | US20110124714 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 05/26/2011 | US20110124583 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 05/26/2011 | US20110124582 Novel polypeptide having anti-tumor activity |
| 05/26/2011 | US20110124581 Nucleic and amino acid sequences for the control of pathogen agents |
| 05/26/2011 | US20110124580 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/26/2011 | US20110124576 Transferrin Variants and Conjugates |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124565 Modified Coagulation Factor VIII With Enhanced Stability and Its Derivatives |
| 05/26/2011 | US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| 05/26/2011 | US20110124556 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 05/26/2011 | US20110124554 Fibrosuppressant Biotherapeutics |
| 05/26/2011 | US20110124553 Insulin-oligomer conjugates, formulations and uses thereof |
| 05/26/2011 | US20110124552 GMCSF and Truncated CCL2 Conjugates and Methods and Uses Thereof |
| 05/26/2011 | US20110124125 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | US20110124085 Unsymmetrical cyanine dimer compounds and their application |
| 05/26/2011 | US20110124081 Nuclear factor of activated t cells receptor |
| 05/26/2011 | US20110124066 Production of itaconic acid |
| 05/26/2011 | US20110124047 Vmp-like sequences of pathogenic borrelia species and strains |
| 05/26/2011 | US20110124046 Extracellular Secretion of Recombinant Proteins |
| 05/26/2011 | US20110124015 Aptamer-based methods for identifying cellular biomarkers |
| 05/26/2011 | US20110123998 Materials and Methods for Treatment of Cancer |
| 05/26/2011 | US20110123995 Treatment of disease |
| 05/26/2011 | US20110123984 Fam26c polymorphisms and use thereof for the diagnostic and treatment of late onset alzheimer's disease |
| 05/26/2011 | US20110123565 Structural Proteins of Fish Pancreatic Disease Virus and Uses Thereof |
| 05/26/2011 | US20110123560 Infectious Bursal Disease Virus Antigenic Isolates And Vaccines |
| 05/26/2011 | US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 05/26/2011 | US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use |
| 05/26/2011 | US20110123548 Compositions and methods for the treatment and diagnosis of immune disorders |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123520 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 05/26/2011 | US20110123492 Immunity-inducing agent |
| 05/26/2011 | US20110123481 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
| 05/26/2011 | US20110123480 Chimeric proteins and uses thereof |
| 05/26/2011 | US20110123448 Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | US20110123441 Novel greb1a monoclonal antibody |
| 05/26/2011 | CA2781560A1 Viral citrullinated peptides and uses thereof |
| 05/26/2011 | CA2781537A1 Recombinant filaggrin polypeptides for cell importation |
| 05/26/2011 | CA2781532A1 Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1 |
| 05/26/2011 | CA2781433A1 Suppression of cancer metastasis |
| 05/26/2011 | CA2781405A1 Melanocortin-1 receptor-specific linear peptides |
| 05/26/2011 | CA2781126A1 Variegation in plants |
| 05/26/2011 | CA2781117A1 Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 05/26/2011 | CA2781110A1 Peptides and methods for the detection of lyme disease antibodies |
| 05/26/2011 | CA2781099A1 Improved bacterial membrane protein secrection |
| 05/26/2011 | CA2781032A1 Ifny inhibitors in the treatment of motoneuron diseases |
| 05/26/2011 | CA2780942A1 Method for treating blood plasma including a step of washing by means of dispersion |
| 05/26/2011 | CA2780807A1 Methods, devices, kits and compositions for detecting roundworm |
| 05/26/2011 | CA2780678A1 Compositions for increasing polypeptide stability and activity, and related methods |
| 05/26/2011 | CA2780527A1 Sucrose transporter genes for increasing plant seed lipids |
| 05/26/2011 | CA2780487A1 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 05/25/2011 | EP2325652A2 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 05/25/2011 | EP2325335A2 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325316A1 Novel hemopoietin receptor protein, nr10 |
| 05/25/2011 | EP2325308A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 05/25/2011 | EP2325203A2 Cadherin materials and methods |
| 05/25/2011 | EP2325202A1 Uses of interferons with altered spatial structure |
| 05/25/2011 | EP2325201A1 Use of il-6-type Cytokines for maturation of Oocytes |
| 05/25/2011 | EP2325200A1 Sclerostin binding agents |
| 05/25/2011 | EP2325199A1 Sclerostin binding agents |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2325197A2 Expression control elements from the Lemnaceae family |
| 05/25/2011 | EP2325196A1 Replikin peptides and uses thereof |
| 05/25/2011 | EP2325195A1 Viral citrullinated peptides and uses thereof |
| 05/25/2011 | EP2325194A1 Process for the purification of glycoproteins |
| 05/25/2011 | EP2324855A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 05/25/2011 | EP2324847A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors |
| 05/25/2011 | EP2324844A2 April receptor (BCMA) and uses thereof |
| 05/25/2011 | EP2324842A1 Immunity-inducing agent |
| 05/25/2011 | EP2324834A2 Methods of Increasing Endogenous Erythropoietin (EPO) |
| 05/25/2011 | EP2324113A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 05/25/2011 | EP2324112A1 Mutant pestivirus with mutations in core gene and ns3 region |
| 05/25/2011 | EP2324065A1 A heparan sulphate which binds bmp2 |
| 05/25/2011 | EP2324062A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 05/25/2011 | EP2324058A1 Biological applications of steroid binding domains |
| 05/25/2011 | EP2324057A1 Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers |
| 05/25/2011 | EP2324056A1 Growth hormone conjugate with increased stability |
| 05/25/2011 | EP2324055A2 Pd-1 antagonists and methods of use thereof |
| 05/25/2011 | EP2324054A2 Phosphopeptides and use of the same |
| 05/25/2011 | EP2324053A2 Ferritin 2 for the host immunization against ticks |
| 05/25/2011 | EP2324052A1 Marker of streptococcus anginosus / streptococcus constellatus (moac) and uses thereof |
| 05/25/2011 | EP2324051A1 Non-typhoidal salmonella vaccines |
| 05/25/2011 | EP2324050A1 Vaccine compositions |
| 05/25/2011 | EP2324049A2 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 05/25/2011 | EP2324048A2 Peptide therapeutics that bind vegf and methods of use thereof |
| 05/25/2011 | EP2324044A2 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 05/25/2011 | EP2323979A1 Treatment or prevention of hepatitis c with immunomodulator compounds |
| 05/25/2011 | EP2323685A2 Agonists of nr2f6 for immunosuppression |
| 05/25/2011 | EP2323635A2 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
| 05/25/2011 | EP2323499A1 Production of canola protein isolate without heat treatment |
| 05/25/2011 | EP1973937B1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 05/25/2011 | EP1934351B1 Abiotic stress tolerant gene from avicennia marina encoding a protein |
| 05/25/2011 | EP1499731B1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |